AWR Lloyd advises on sale of Vietnam pharmaceutical firm to Korea’s JW group
In 2019, AWR Lloyd advised the FIT Group, one of Vietnam’s fastest growing conglomerates, on the divestment of their shareholding in Euvipharm, a Vietnamese pharmaceuticals company, to Korean group, JW Pharmaceutical Corporation. The transaction was completed in December 2019.
JW Pharmaceutical Corporation is a pharmaceutical company in Korea with core competencies in antibiotics, IV solutions, and anti-cancer treatments. JW Pharmaceutical Corporation is currently exploring targeted therapies in oncology leveraging the collaborative research and development strengths of the JW Drug Discovery Center in Korea and the JW Theriac Corp in the US. JW Pharmaceuticals is part of the JW Group which consists of JW Holdings, JW Pharmaceutical, JW Medical, JW ShinYak, JW Industrial, JW Life Science, and JW Creagene.
Founded in 2005, Euvipharm was acquired by Valeant, Canada’s largest drug maker in 2013 and then by FIT Group in 2017. Euvipharm is headquartered in the South of Vietnam and operates state-of-the-art WHO-GMP standard factories. Euvipharm is now one of a few cases of a pharmaceuticals company which is 100% foreign-owned in Vietnam.
AWR Lloyd has been active in Vietnam since 2004 advising both Vietnamese and international clients on strategy and investment transactions. AWR Lloyd’s Vietnam & Northeast Asia team is led by Managing Director Ms. Tuong Thi Thu Hanh in Ho Chi Minh City. Ms. Hanh has over 20 years of investment banking experience in Vietnam and was previously with PetroVietnam Securities, ACB Securities and BIDV.
AWR Lloyd is a specialist strategy and transactions advisory firm focused on the Asia-Pacific region. The firm has a 20-year track record delivering bespoke strategic advice, M&A support and industry intelligence to some of the world’s biggest and most successful companies in the oil and gas, mining and metals, power, renewables, energy technology, infrastructure and financial services sectors.
For more information please contact us at email@example.com